AGLE-325

N/A

Report date: 2023/01/07 22:56:47

Base Information

Drug NameAGLE-325
Drug Alias NameAGLE325
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Enzyme
Mechanisms of ActionEnzyme replacements
TargetsNot applicable
Therapy Area/IndicationsCystinuria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAeglea Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAeglea Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsCystinuria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A